Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza ▿
Identifieur interne : 000778 ( Pmc/Checkpoint ); précédent : 000777; suivant : 000779Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza ▿
Auteurs : M. Jaber Hossain [Géorgie (pays), États-Unis] ; Melissa Bourgeois [Géorgie (pays)] ; Fu-Shi Quan [Géorgie (pays)] ; Aleksandr S. Lipatov [Géorgie (pays)] ; Jae-Min Song [Géorgie (pays), États-Unis] ; Li-Mei Chen [Géorgie (pays)] ; Richard W. Compans [Géorgie (pays)] ; Ian York [Géorgie (pays)] ; Sang-Moo Kang [Géorgie (pays), États-Unis] ; Ruben O. Donis [Géorgie (pays)]Source :
- Clinical and Vaccine Immunology : CVI [ 1556-6811 ] ; 2011.
Abstract
Immunization of the world population before an influenza pandemic such as the 2009 H1N1 virus spreads globally is not possible with current vaccine production platforms. New influenza vaccine technologies, such as virus-like-particles (VLPs), offer a promising alternative. Here, we tested the immunogenicity and protective efficacy of a VLP vaccine containing hemagglutinin (HA) and M1 from the 2009 pandemic H1N1 influenza virus (H1N1pdm) in ferrets and compared intramuscular (i.m.) and intranasal (i.n.) routes of immunization. Vaccination of ferrets with VLPs containing the M1 and HA proteins from A/California/04/2009 (H1N1pdm) induced high antibody titers and conferred significant protection against virus challenge. VLP-vaccinated animals lost less weight, shed less virus in nasal washes, and had markedly lower virus titers in all organs tested than naïve controls. A single dose of VLPs, either i.m. or i.n., induced higher levels of antibody than did two doses of commercial split vaccine. Ferrets vaccinated with split vaccine were incompletely protected against challenge; these animals had lower virus titers in olfactory bulbs, tonsils, and intestines, but lost weight and shed virus in nasal washes to a similar extent as naïve controls. Challenge with heterologous A/Brisbane/59/07 (H1N1) virus revealed that the VLPs conferred minimal cross-protection to heterologous infection, as revealed by the lack of reduction in nasal wash and lung virus titers and slightly higher weight loss relative to controls. In summary, these experiments demonstrate the strong immunogenicity and protective efficacy of VLPs compared to the split vaccine and show that i.n. vaccination with VLPs has the potential for highly efficacious vaccination against influenza.
Url:
DOI: 10.1128/CVI.05206-11
PubMed: 22030367
PubMed Central: 3232700
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:3232700Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza <xref ref-type="fn" rid="FN2"><sup>▿</sup>
</xref>
</title>
<author><name sortKey="Hossain, M Jaber" sort="Hossain, M Jaber" uniqKey="Hossain M" first="M. Jaber" last="Hossain">M. Jaber Hossain</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff3">Battelle, Atlanta, Georgia 30333</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Battelle, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bourgeois, Melissa" sort="Bourgeois, Melissa" uniqKey="Bourgeois M" first="Melissa" last="Bourgeois">Melissa Bourgeois</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Quan, Fu Shi" sort="Quan, Fu Shi" uniqKey="Quan F" first="Fu-Shi" last="Quan">Fu-Shi Quan</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lipatov, Aleksandr S" sort="Lipatov, Aleksandr S" uniqKey="Lipatov A" first="Aleksandr S." last="Lipatov">Aleksandr S. Lipatov</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Song, Jae Min" sort="Song, Jae Min" uniqKey="Song J" first="Jae-Min" last="Song">Jae-Min Song</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff4">Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta, Georgia 30303</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Chen, Li Mei" sort="Chen, Li Mei" uniqKey="Chen L" first="Li-Mei" last="Chen">Li-Mei Chen</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Compans, Richard W" sort="Compans, Richard W" uniqKey="Compans R" first="Richard W." last="Compans">Richard W. Compans</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="York, Ian" sort="York, Ian" uniqKey="York I" first="Ian" last="York">Ian York</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kang, Sang Moo" sort="Kang, Sang Moo" uniqKey="Kang S" first="Sang-Moo" last="Kang">Sang-Moo Kang</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff4">Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta, Georgia 30303</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Donis, Ruben O" sort="Donis, Ruben O" uniqKey="Donis R" first="Ruben O." last="Donis">Ruben O. Donis</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22030367</idno>
<idno type="pmc">3232700</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232700</idno>
<idno type="RBID">PMC:3232700</idno>
<idno type="doi">10.1128/CVI.05206-11</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000677</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000677</idno>
<idno type="wicri:Area/Pmc/Curation">000677</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000677</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000778</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000778</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza <xref ref-type="fn" rid="FN2"><sup>▿</sup>
</xref>
</title>
<author><name sortKey="Hossain, M Jaber" sort="Hossain, M Jaber" uniqKey="Hossain M" first="M. Jaber" last="Hossain">M. Jaber Hossain</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff3">Battelle, Atlanta, Georgia 30333</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Battelle, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bourgeois, Melissa" sort="Bourgeois, Melissa" uniqKey="Bourgeois M" first="Melissa" last="Bourgeois">Melissa Bourgeois</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Quan, Fu Shi" sort="Quan, Fu Shi" uniqKey="Quan F" first="Fu-Shi" last="Quan">Fu-Shi Quan</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lipatov, Aleksandr S" sort="Lipatov, Aleksandr S" uniqKey="Lipatov A" first="Aleksandr S." last="Lipatov">Aleksandr S. Lipatov</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Song, Jae Min" sort="Song, Jae Min" uniqKey="Song J" first="Jae-Min" last="Song">Jae-Min Song</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff4">Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta, Georgia 30303</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Chen, Li Mei" sort="Chen, Li Mei" uniqKey="Chen L" first="Li-Mei" last="Chen">Li-Mei Chen</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Compans, Richard W" sort="Compans, Richard W" uniqKey="Compans R" first="Richard W." last="Compans">Richard W. Compans</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="York, Ian" sort="York, Ian" uniqKey="York I" first="Ian" last="York">Ian York</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kang, Sang Moo" sort="Kang, Sang Moo" uniqKey="Kang S" first="Sang-Moo" last="Kang">Sang-Moo Kang</name>
<affiliation wicri:level="1"><nlm:aff id="aff2">Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="aff4">Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta, Georgia 30303</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Donis, Ruben O" sort="Donis, Ruben O" uniqKey="Donis R" first="Ruben O." last="Donis">Ruben O. Donis</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</nlm:aff>
<country xml:lang="fr">Géorgie (pays)</country>
<wicri:regionArea>Influenza Division, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical and Vaccine Immunology : CVI</title>
<idno type="ISSN">1556-6811</idno>
<idno type="eISSN">1556-679X</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Immunization of the world population before an influenza pandemic such as the 2009 H1N1 virus spreads globally is not possible with current vaccine production platforms. New influenza vaccine technologies, such as virus-like-particles (VLPs), offer a promising alternative. Here, we tested the immunogenicity and protective efficacy of a VLP vaccine containing hemagglutinin (HA) and M1 from the 2009 pandemic H1N1 influenza virus (H1N1pdm) in ferrets and compared intramuscular (i.m.) and intranasal (i.n.) routes of immunization. Vaccination of ferrets with VLPs containing the M1 and HA proteins from A/California/04/2009 (H1N1pdm) induced high antibody titers and conferred significant protection against virus challenge. VLP-vaccinated animals lost less weight, shed less virus in nasal washes, and had markedly lower virus titers in all organs tested than naïve controls. A single dose of VLPs, either i.m. or i.n., induced higher levels of antibody than did two doses of commercial split vaccine. Ferrets vaccinated with split vaccine were incompletely protected against challenge; these animals had lower virus titers in olfactory bulbs, tonsils, and intestines, but lost weight and shed virus in nasal washes to a similar extent as naïve controls. Challenge with heterologous A/Brisbane/59/07 (H1N1) virus revealed that the VLPs conferred minimal cross-protection to heterologous infection, as revealed by the lack of reduction in nasal wash and lung virus titers and slightly higher weight loss relative to controls. In summary, these experiments demonstrate the strong immunogenicity and protective efficacy of VLPs compared to the split vaccine and show that i.n. vaccination with VLPs has the potential for highly efficacious vaccination against influenza.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Vaccine Immunol</journal-id>
<journal-id journal-id-type="hwp">cdli</journal-id>
<journal-id journal-id-type="pmc">cvi</journal-id>
<journal-id journal-id-type="publisher-id">CVI</journal-id>
<journal-title-group><journal-title>Clinical and Vaccine Immunology : CVI</journal-title>
</journal-title-group>
<issn pub-type="ppub">1556-6811</issn>
<issn pub-type="epub">1556-679X</issn>
<publisher><publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">22030367</article-id>
<article-id pub-id-type="pmc">3232700</article-id>
<article-id pub-id-type="publisher-id">5206-11</article-id>
<article-id pub-id-type="doi">10.1128/CVI.05206-11</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Vaccine Research</subject>
</subj-group>
</article-categories>
<title-group><article-title>Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza <xref ref-type="fn" rid="FN2"><sup>▿</sup>
</xref>
</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Hossain</surname>
<given-names>M. Jaber</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Bourgeois</surname>
<given-names>Melissa</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Quan</surname>
<given-names>Fu-Shi</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">†</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lipatov</surname>
<given-names>Aleksandr S.</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Song</surname>
<given-names>Jae-Min</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Chen</surname>
<given-names>Li-Mei</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Compans</surname>
<given-names>Richard W.</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>York</surname>
<given-names>Ian</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Kang</surname>
<given-names>Sang-Moo</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Donis</surname>
<given-names>Ruben O.</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="aff1"><label>1</label>
Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia</aff>
<aff id="aff2"><label>2</label>
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia</aff>
<aff id="aff3"><label>3</label>
Battelle, Atlanta, Georgia 30333</aff>
<aff id="aff4"><label>4</label>
Center for Inflammation, Immunity & Infection, Department of Biology, Georgia State University, Atlanta, Georgia 30303</aff>
</contrib-group>
<author-notes><corresp id="cor1"><label>*</label>
Corresponding author. Mailing address: <addr-line>Influenza Division, Mailstop G-16, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333</addr-line>
. Phone: <phone>(404) 639-4968</phone>
. Fax: <fax>(404) 639-2350</fax>
. E-mail: <email>rvd6@cdc.gov</email>
.</corresp>
<fn fn-type="present-address" id="FN1"><label>†</label>
<p>Present address: Department of Biotechnology, Chungju National University, Jeungpyeong, 368-701 Korea.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub"><month>12</month>
<year>2011</year>
</pub-date>
<volume>18</volume>
<issue>12</issue>
<fpage>2010</fpage>
<lpage>2017</lpage>
<history><date date-type="received"><day>6</day>
<month>6</month>
<year>2011</year>
</date>
<date date-type="rev-request"><day>12</day>
<month>7</month>
<year>2011</year>
</date>
<date date-type="accepted"><day>17</day>
<month>10</month>
<year>2011</year>
</date>
</history>
<permissions><copyright-statement>Copyright © 2011, American Society for Microbiology. All Rights Reserved.</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder>American Society for Microbiology</copyright-holder>
</permissions>
<self-uri xlink:title="pdf" xlink:type="simple" xlink:href="zcd01211002010.pdf"></self-uri>
<abstract><p>Immunization of the world population before an influenza pandemic such as the 2009 H1N1 virus spreads globally is not possible with current vaccine production platforms. New influenza vaccine technologies, such as virus-like-particles (VLPs), offer a promising alternative. Here, we tested the immunogenicity and protective efficacy of a VLP vaccine containing hemagglutinin (HA) and M1 from the 2009 pandemic H1N1 influenza virus (H1N1pdm) in ferrets and compared intramuscular (i.m.) and intranasal (i.n.) routes of immunization. Vaccination of ferrets with VLPs containing the M1 and HA proteins from A/California/04/2009 (H1N1pdm) induced high antibody titers and conferred significant protection against virus challenge. VLP-vaccinated animals lost less weight, shed less virus in nasal washes, and had markedly lower virus titers in all organs tested than naïve controls. A single dose of VLPs, either i.m. or i.n., induced higher levels of antibody than did two doses of commercial split vaccine. Ferrets vaccinated with split vaccine were incompletely protected against challenge; these animals had lower virus titers in olfactory bulbs, tonsils, and intestines, but lost weight and shed virus in nasal washes to a similar extent as naïve controls. Challenge with heterologous A/Brisbane/59/07 (H1N1) virus revealed that the VLPs conferred minimal cross-protection to heterologous infection, as revealed by the lack of reduction in nasal wash and lung virus titers and slightly higher weight loss relative to controls. In summary, these experiments demonstrate the strong immunogenicity and protective efficacy of VLPs compared to the split vaccine and show that i.n. vaccination with VLPs has the potential for highly efficacious vaccination against influenza.</p>
</abstract>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>Géorgie (pays)</li>
<li>États-Unis</li>
</country>
<region><li>Géorgie (États-Unis)</li>
</region>
</list>
<tree><country name="Géorgie (pays)"><noRegion><name sortKey="Hossain, M Jaber" sort="Hossain, M Jaber" uniqKey="Hossain M" first="M. Jaber" last="Hossain">M. Jaber Hossain</name>
</noRegion>
<name sortKey="Bourgeois, Melissa" sort="Bourgeois, Melissa" uniqKey="Bourgeois M" first="Melissa" last="Bourgeois">Melissa Bourgeois</name>
<name sortKey="Chen, Li Mei" sort="Chen, Li Mei" uniqKey="Chen L" first="Li-Mei" last="Chen">Li-Mei Chen</name>
<name sortKey="Compans, Richard W" sort="Compans, Richard W" uniqKey="Compans R" first="Richard W." last="Compans">Richard W. Compans</name>
<name sortKey="Donis, Ruben O" sort="Donis, Ruben O" uniqKey="Donis R" first="Ruben O." last="Donis">Ruben O. Donis</name>
<name sortKey="Kang, Sang Moo" sort="Kang, Sang Moo" uniqKey="Kang S" first="Sang-Moo" last="Kang">Sang-Moo Kang</name>
<name sortKey="Lipatov, Aleksandr S" sort="Lipatov, Aleksandr S" uniqKey="Lipatov A" first="Aleksandr S." last="Lipatov">Aleksandr S. Lipatov</name>
<name sortKey="Quan, Fu Shi" sort="Quan, Fu Shi" uniqKey="Quan F" first="Fu-Shi" last="Quan">Fu-Shi Quan</name>
<name sortKey="Song, Jae Min" sort="Song, Jae Min" uniqKey="Song J" first="Jae-Min" last="Song">Jae-Min Song</name>
<name sortKey="York, Ian" sort="York, Ian" uniqKey="York I" first="Ian" last="York">Ian York</name>
</country>
<country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Hossain, M Jaber" sort="Hossain, M Jaber" uniqKey="Hossain M" first="M. Jaber" last="Hossain">M. Jaber Hossain</name>
</region>
<name sortKey="Kang, Sang Moo" sort="Kang, Sang Moo" uniqKey="Kang S" first="Sang-Moo" last="Kang">Sang-Moo Kang</name>
<name sortKey="Song, Jae Min" sort="Song, Jae Min" uniqKey="Song J" first="Jae-Min" last="Song">Jae-Min Song</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000778 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000778 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:3232700 |texte= Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza ▿ }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:22030367" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
![]() | This area was generated with Dilib version V0.6.34. | ![]() |